• Profile
Close

Treatment of hypertension with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross-sectional study

The Journal of Clinical Hypertension Dec 06, 2021

Pedrianes-Martin PB, Martin-Rincon M, Morales-Alamo D, et al. - Treatment with antihypertensive medications that antagonize the renin-angiotensin system may confer normalization of elevated resting metabolic rate (RMR) per kg of lean body mass (LBM).

  • Hypertension in obese and overweight patients is linked with an increased RMR.

  • Participants were 174 volunteers; 93 (46.5 %) with hypertension, of which 16 men and 13 women were treated with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin blockers (ARB), while 30 men and 19 women with untreated hypertension formed the control group.

  • Compared with ACEI/ARB-treated hypertensive women, the untreated ones exhibited 15% higher RMR normalized to the LBM.

  • Patients taking ACEI/ARB had 2.9% lower RMR, post-accounting for LBM, whole-body fat mass, age, the double product (heart rate x systolic blood pressure), and the distance walked per day.

  • Relative to males, untreated hypertensive overweight and obese females exhibited a greater RMR per kg of LBM, while this gender disparity was absent in patients treated with ACEI or ARBs.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay